Functional regulation and proteomic characterization of human natural killer cells through recombinant human granulocyte-colony stimulating factor treatment

Proteomics - Clinical Applications

Volumn 3, Issue 5, 2009, Pages 563-573

  Chen, Yu Jen ^a,b   Yu, Chih Chia ^c   Chen, Shui Tein ^d,e   Chen, Tai Yuan ^d   Liao, Hui Fen ^c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b CHINESE CULTURE UNIVERSITY   (Taiwan)

^c NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^d ACADEMIA SINICA   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cytokines; Cytotoxicity; G CSF; Natural killer cells; Nitric oxide

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; ONCOPROTEIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL COUNT; CELL MEDIATED CYTOTOXICITY; CELL STRAIN K 562; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; GENE EXPRESSION PROFILING; GLYCOLYSIS; HUMAN; HUMAN CELL; INFLAMMATION; NATURAL KILLER CELL; NORMAL HUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; PROTEOMICS; REGULATORY MECHANISM;

EID: 67649429400     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200800113     Document Type: Article

References (41)

1. Joshi, S. S., Lynch, J. C., Pavletic, S. Z., Tarantolo, S. R. et al., Decreased immune functions of blood cells following mobilization with granulocyte colony-stimulating factor: association with donor characteristics. Blood 2001, 98, 1963-1970.
2. Pavletic, Z. S., Joshi, S. S., Pirruccello, S. J., Tarantolo, S. R. et al., Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancy. Bone Marrow Transplant. 1998, 21, 33-41.
3. Kusano, K., Ebara, S., Tachibana, K., Nishimura, T. et al., Apotential therapeutic role for small nonpeptidyl compounds that mimic human granulocyte colony-stimulating factor. Blood 2004, 103, 836-842.
4. Sloand, E. M., Kim, S., Maciejewski, J. P., Rhee, F. V. et al., Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood 2000, 95, 2269-2274.
5. Young, H. A., Ortaldo, J., Cytokines as critical co-stimulatory molecules in modulating the immune response of natural killer cells. Cell Res. 2006, 16, 20-24.
6. Kagi, D., Vignaux, F., Ledermann, B., Burki, K. et al., Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994, 265, 528.
7. Cooper, M. A., Fehniger, T. A., Caligiuri, M. A., The biology of human natural killer-cell subsets. Trends Immunol. 2001, 22, 633-640.
8. Orange, J. S., Ballas, Z. K., Natural killer cells in human health and disease. Clin. Immunol. 2006, 118, 1-10.
9. Robertson, M. J., Soiffer, R. J., Wolf, S. F., Manley, T. J. et al., Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J. Exp. Med. 1992, 175, 779-788.
10. Dimasi, N., Biassoni, R., Structural and functional aspects of the Ly49 natural killer cell receptors. Immunol. Cell Biol. 2005, 83, 1-8.
11. Hamerman, J. A., Ogasawara, K., Lanier, L. L., NK cells in innate immunity. Curr. Opin. Immunol. 2005, 17, 29-35.
12. Bottino, C., Castriconi, R., Moretta, L., Moretta, A., Cellular ligands of activating NK receptors. Trends Immunol. 2005, 26, 221-226.
13. Miller, J. S., Prosper, F., McCullar, V., Natural killer (NK) cells are functionally abnormal and NK cells are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections. Blood 1997, 90, 3098-3105.
14. Verma, U. N., Yankelevich, B., Hodgson, J., Mazumder, A., Effect of the in vivo priming regimen for peripheral peripheral blood stem cells (PBSC) mobilization on in vitro generation of cytotoxic effectors by IL-2 activation of PBSC in a murine model. Bone Marrow Transplant. 1997, 19, 265-273.
15. Rondelli, D., Raspodiri, D., Anasetti, C., Bandini, G. et al., Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cells. Bone Marrow Transplant. 1998, 22, 631-637.
16. Joshi, S. S., Lynch, J. C., Pavletic, S. Z., Tarantolo, S. R. et al., Decreased immune functions of blood cells following mobilization with granulocyte colony-stimulating factor: association with donor characteristics. Blood 2001, 98, 1963-1970.
17. Kitabayashi, A., Hirokawa, M., Hatano, Y., Lee, M. et al., Granulocyte colony-stimulating factor downregulates allogeneic immune responses by posttranscriptional inhibition of tumor necrosis factor- production. Blood 1995, 86, 2220-2227.
18. Liao, H. F., Chen, Y. J., Yang, Y. C., A novel polysaccharide of black soybean promotes myelopoiesis and reconstitutes bone marrow after 5-flurouracil- and irradiation-induced myelosuppression. Life Sci. 2005, 77, 400-413.
19. Lemoli, R. M., Bandini, G., Leopardi, G., Rosti, G. et al., Allogeneic peripheral blood stem cell transplantation in patients with early phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation. Haematologica 1998, 83, 48-55.
20. Rondelli, D., Raspadori, D., Anasetti, C., Bandini, C. et al., Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cells. Bone Marrow Transplant. 1998, 22, 631-637.
21. Gratwohl, A., Baldomero, H., Passweg, J., Frassoni, F. et al., Hematopoietic stem cell transplantation for hematological malignancies in Europe. Leukemia 2003, 17, 941-959.
22. Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K. et al., Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002, 295, 2097-2100.
23. Miller, J. S., Prosper, F., McCullar, V., Natural killer (NK) cells are functionally abnormal and NK cell progenitors are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections. Blood 1997, 90, 3093-3105.
24. Taga, T., Kariya, Y., Shimada, M., Uchida, A., Suppression of natural killer cell activity by granulocytes in patients with aplastic anemia: role of granulocyte colony-stimulating factor. Immunol. Lett. 1993, 39, 65-70.
25. Welte, K., Gabrilove, J., Bronchud, M. H., Platzer, E., Morstyn, G., Filgrastim (r-metHuG-CSF): the first 10 years. Blood 1996, 88, 1907-1929.
26. Kubista, B., Trieb, K., Herbacek, I., Micksche, M., Effect of granulocyte-macrophage colony stimulating factor on natural-killer cell mediated cytotoxicity. Int. J. Biochem. Cell Biol. 2003, 35, 1056-1060.
27. Carcamo, J. M., Borquez-Ojeda, O., Golde, D. W., Vitamin C inhibits granulocyte macrophage-colony-stimulating factorinduced signaling pathways. Blood 2002, 99, 3205-3212.
28. Sheibani, N., Grabowski, E. F., Schoenfeld, D. A., Whalen, M. J., Effect of granulocyte colony-stimulating factor on functional and histopathologic outcome after traumatic brain injury in mice. Crit. Care Med. 2004, 32, 2274-2278.
29. Gardner, C. R., Laskin, J. D., Dambach, D. M., Chiu, H. et al., Exaggerated hepatotoxicity of acetaminophen in mice lacking tumor necrosis factor receptor-1. Potential role of inflammatory mediators. Toxicol. Appl. Pharmacol. 2003, 192, 119-130.
30. Cifone, M. G., D'Alo, S., Parroni, R., Millimaggi, D. et al., Interleukin-2-activated rat natural killer cells express inducible nitric oxide synthase that contributes to cytotoxic function and interferon-gamma production. Blood 1999, 93, 3876-3884.
31. Plas, D. R., Rathmell, J. C., Thompson, C. B., Homeostatic control of lymphocyte survival: potential origins and implications. Nat. Immunol. 2002, 3, 515-521.
32. Khelifi, A. F., D'Alcontres, M. S., Salomoni, P., Daxx is required for stress-induced cell death and JNK activation. Cell Death Differ. 2005, 12, 724-733.
33. Prochazka, G., Landon, C., Dennert, G., Transmembrane chloride flux is required for target cell lysis but not for Golgi reorientation in cloned cytolytic effector cells. Golgi reorientation, N alpha benzyloxycarbonyl L-lysine thiobenzyl ester serine esterase release, and delivery of the lethal hit are separable events in target cell lysis. J. Immunol. 1988, 141, 1288-1294.
34. Andrin, C., Pinkoski, M. J., Burns, K., Atkinson, E. A. et al., Interaction between a Ca2+-binding protein calreticulin and perforin, a component of the cytotoxic T-cell granules. Biochemistry 1998, 37, 10386-10394.
35. Fraser, S. A., Karimi, R., Michalak, M., Hudig, D., Perforin lytic activity is controlled by calreticulin. J. Immunol. 2000, 164, 4150-4155.
36. Ferlazzo, V., D'Agostino, P., Milano, S., Caruso, R. et al., Anti-inflammatory effects of annexin-1: stimulation of IL-10 release and inhibition of nitric oxide synthesis. Int. Immunopharmacol. 2003, 3, 1363-1369.
37. Wang, J., Maldonado, M. A., The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases. Cell. Mol. Immunol. 2006, 3, 255-261.
38. Fukushima, T., Matsuzawa, S., Kress, C. L., Bruey, J.M. et al., Ubiquitin-conjugating enzyme Ubc13 is a critical component of TNF receptor-associated factor (TRAF)-mediated inflammatory responses. Proc. Natl. Acad. Sci. USA 2007, 104, 6371-6376.
39. Lu, M., Kitson, R. P., Xue, Y., Goldfarb, R. H., Activation of multiple caspases and modification of cell surface fas (CD95) in proteasome inhibitor-induced apoptosis of rat natural killer cells. J. Cell. Biochem. 2003, 88, 482-492.
40. Yokoyama, W. M., Riley, J. K., NK cells and their receptors. Reprod. Biomed. Online 2008, 16, 173-191.
41. Nile, C. J., Townes, C. L., Michailidis, G., Hirst, B. H., Hall, J., Identification of chicken lysozyme 2 and its expression in the intestine. Cell Mol. Life Sci. 2004, 61, 2760-2766.